The CB1 Cannabinoid Receptor Activation By Protein Molecular Dynamics Simulations
通过蛋白质分子动力学模拟激活 CB1 大麻素受体
基本信息
- 批准号:7263293
- 负责人:
- 金额:$ 10.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAreaBindingBiomedical ResearchBiophysicsBiotechnologyBrainC-terminalCNR1 geneChemistryComplexDockingEnvironmental HealthFacility Construction Funding CategoryFamilyFutureG-Protein-Coupled ReceptorsGTP-Binding ProteinsGoalsHealth Services ResearchHelix (Snails)IllinoisInstitutesKnowledgeLaboratoriesLeadLigand BindingLigandsLymphocyte Antigen 96Mentored Research Scientist Development AwardMentorsModelingMolecularMolecular ConformationNorth CarolinaPharmaceutical PreparationsPharmacologyPrincipal InvestigatorPropertyProtein AnalysisProteinsReceptor ActivationResearchResearch InstituteRotationSolidStructureSupervisionSystemTechniquesTimeUniversitiesVertebral columnWatercannabinoid receptordriving forceear helixextracellularmembermolecular dynamicsmolecular modelingoctaneprogramsprotein activationreceptorreceptor bindingsimulationstructural biology
项目摘要
DESCRIPTION (provided by applicant): This Mentored Research Scientist Development Award (K01) is to develop the research program of Dr. Joong-Youn Shim in the Julius L. Chambers Biomedical/Biotechnology Research Institute (JLC-BBRI) at North Carolina Central University (NCCU). To achieve the scientific goals, protein modeling will be utilized for the study the ligand-CB1 receptor-Galphai complex under the supervision of computational and pharmacology experts. The current proposal will allow to obtain solid and broad knowledge of protein modeling and will lead to be equipped with capability to address many challenging issues important in biomedical research area in the future. This research will be supervised by Dr. Thomas Darden (Principal Investigator, Laboratory of Structural Biology, National Institute of Environmental Health Sciences, RTF, NC) as the scientific mentor and Dr. Allyn C. Hewlett (Director, Neurosci./Drug Abuse Res. Program, JLC-BBRI, Durham, NC) as the scientific comentor, and Drs. Brian Thomas (Director, Center for Chemistry Services, Research Triangle Institute, RTP, NC) and Emad Tajkhorshid (Assistant Director of Research, Theoretical & Computational Biophysics Group, University of Illinois at Urbana-Champaign, Beckman Institute, IL) as the scientific advisory members. The major goal of the proposed research is to demonstrate that the ligand can trigger to induce or stabilize receptor serial micro-conformational changes requisite to G-protein activation by using a protein MD simulations approach. The SPECIFIC AIMS are: 1) Construction of a molecular model, including the transmembrane (TM) helices, the extracellular/ intracellular loops, and the shortened N- and C-terminals of the brain CB1 receptor in complex with GalphaM; 2) Protein MD simulations of the CB1 receptor-Galphai 1 complex; 3) Conversion of the inactive CB1 receptor to its active form by protein MD simulations of the ligand-CB1 receptor-Galphah complex; and 4) Analysis of the protein MD simulation results.
描述(由申请人提供):本导师研究科学家发展奖(K01)旨在发展北卡罗莱纳中央大学朱利叶斯L.钱伯斯生物医学/生物技术研究所(jlc - bri)的沈仲渊博士的研究项目。为了实现科学目标,将在计算和药理学专家的监督下,利用蛋白质模型对配体- cb1受体- galphai复合物进行研究。目前的提案将允许获得扎实而广泛的蛋白质建模知识,并将导致具备解决未来生物医学研究领域许多具有挑战性的重要问题的能力。本研究将由Thomas Darden博士(国家环境健康科学研究所结构生物学实验室首席研究员,RTF, NC)作为科学导师和Allyn C. Hewlett博士(神经科学主任)指导。/药物滥用计划,jlc - bri, Durham, NC)作为科学评论员。Brian Thomas(北卡罗来纳州RTP三角研究所化学服务中心主任)和Emad Tajkhorshid(伊利诺伊大学厄巴纳-香槟分校贝克曼研究所理论与计算生物物理小组研究助理主任)为科学顾问成员。该研究的主要目的是通过蛋白质MD模拟方法证明配体可以触发诱导或稳定g蛋白激活所需的受体系列微构象变化。具体目的是:1)构建脑CB1受体与GalphaM复合物的分子模型,包括跨膜螺旋、胞外/胞内环以及缩短的N和c端;2) CB1受体- galphai复合物的蛋白MD模拟;3)通过配体-CB1受体- galphah复合物的蛋白MD模拟将无活性CB1受体转化为活性形式;4)蛋白质MD模拟结果分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOONG-YOUN SHIM其他文献
JOONG-YOUN SHIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOONG-YOUN SHIM', 18)}}的其他基金
The CB1 Cannabinoid Receptor Activation By Protein Molecular Dynamics Simulations
通过蛋白质分子动力学模拟激活 CB1 大麻素受体
- 批准号:
8034803 - 财政年份:2007
- 资助金额:
$ 10.49万 - 项目类别:
The CB1 Cannabinoid Receptor Activation By Protein Molecular Dynamics Simulations
通过蛋白质分子动力学模拟激活 CB1 大麻素受体
- 批准号:
7791315 - 财政年份:2007
- 资助金额:
$ 10.49万 - 项目类别:
The CB1 Cannabinoid Receptor Activation By Protein Molecular Dynamics Simulations
通过蛋白质分子动力学模拟激活 CB1 大麻素受体
- 批准号:
7391569 - 财政年份:2007
- 资助金额:
$ 10.49万 - 项目类别:
The CB1 Cannabinoid Receptor Activation By Protein Molecular Dynamics Simulations
通过蛋白质分子动力学模拟激活 CB1 大麻素受体
- 批准号:
7587309 - 财政年份:2007
- 资助金额:
$ 10.49万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 10.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 10.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 10.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)